Acute metonitazene poisoning reversed by naloxone
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
"Acute metonitazene poisoning reversed by naloxone." Clinical Toxicology, 61(2), pp. 137–138
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Krotulski, A. J., Papsun, D. M., Walton, S. E., & Logan, B. K. (2021) · Drug Testing and Analysis · doi:10.1002/dta.3115 · Cited by 91 · cited 1×
“use disorder prior to their deaths [2].”
Montanari, E., Madeo, G., Pichini, S., Busardò, F. P., & Carlier, J. (2022) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000970 · Cited by 89 · cited 3×
“It is suggested that additional naloxone doses might be required for metonitazene overdose [3], and detection of naloxone in biological samples of deaths implies the low efficacy of naloxone [1].”
BackgroundInfluentialSchumann, J. L., Syrjanen, R., Alford, K., Mashetty, S., Castle, J. W., Rotella, J., Maplesden, J., & Greene, S. L. (2023) · Journal of Analytical Toxicology · doi:10.1093/jat/bkac062 · Cited by 61 · cited 2×
“This case describes the early use of ECMO for a severe chemical pneumonitis adding to its previously described use for the management of acute respiratory distress syndrome (ARDS) following toxic gas exposures [3,4].”
BackgroundTrecki, J., Gerona, R. R., Ellison, R., Thomas, C., & Mileusnic-Polchan, D. (2022) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7104a3 · Cited by 28
Cited by
Vandeputte, M. M., & Stove, C. P. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110470 · Cited by 36
Nitazenes: review of comparative pharmacology and antagonist action
Stangeland, M., Dale, O., & Skulberg, A. K. (2025) · Clinical Toxicology · doi:10.1080/15563650.2025.2504133 · Cited by 34
“Metonitazene, other opioids, and benzodiazepines were reversed by naloxone 0.20 mg and flumazenil 2.00 mg, likely intravenously [41]. white et al. [46] reported the reversal of metonitazene poisoning using naloxone 0.40 mg intravenously.”
InfluentialNaloxone Dosing and Hospitalization for Nitazene Overdose: A Scoping Review
Berger, J. C., Severe, A. D., Jalloh, M. S., & Manini, A. F. (2025) · Journal of Medical Toxicology · doi:10.1007/s13181-025-01059-8 · Cited by 19
“In this case, the overdose was reversed with a single dose of naloxone [21].”
Curtis, B., Lawes, D. J., Caldicott, D., & McLeod, M. D. (2025) · Drug Testing and Analysis · doi:10.1002/dta.3910 · Cited by 19
“Both NPP and NPI are powerful activators of the μ-opioid receptor, as demonstrated by their in vitro EC 50 values for stimulation of [ 35 S]GTPγS binding to activated G-proteins [5], β-arrestin 2 recruitment (MOR-βarr2) or inhibition of cAMP accumulation [6].”
InfluentialSyrjanen, R., Schumann, J. L., Castle, J. W., Sharp, L., Griffiths, A., Blakey, K., Dutch, M., Maplesden, J., & Greene, S. L. (2024) · Clinical Toxicology · doi:10.1080/15563650.2024.2383692 · Cited by 19
Metadata
- Authors
- White, A., Seah, V., Brown, J., McDonald, C., Tran, J., & Roberts, D. M.
- Venue
- Clinical Toxicology
- Publisher
- Informa UK Limited
- Published
- 2023-02-01
- Volume
- 61
- Issue
- 2
- Pages
- 137-138
- ISSN
- 0009-9309 (ISSN-L)
- 1556-3650
- 1556-9519
- OpenAlex
- W4319826212
- Cited by
- 12
- References
- 4
- FWCI
- 3.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acute metonitazene poisoning reversed by naloxone. https://app.cochat.ai/papers/10.1080/15563650.2022.2164505
- The paper
- White, A., Seah, V., Brown, J., McDonald, C., Tran, J., & Roberts, D. M. (2023). Acute metonitazene poisoning reversed by naloxone. Clinical Toxicology. https://doi.org/10.1080/15563650.2022.2164505
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.